Informazioni sul prodotto
- 1-[(3α,5β)-3-Hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl]-1H-pyrazole-4-carbonitrile
- Zuranolone
- 1H-Pyrazole-4-carbonitrile, 1-[(3α,5β)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl]-
- SAGE 217
- 1-[2-[(3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl]pyrazole-4-carbonitrile
- 1H-Pyrazole-4-carbonitrile, 1-[(3α,5β)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl]-
- SGE 797
SAGE-217 is a novel antidepressant drug that has been shown to be effective in the treatment of depression. The drug is orally administered and is rapidly absorbed, with peak plasma concentrations occurring within one hour. It binds to GABA receptors and blocks the binding of the neurotransmitter gamma-aminobutyric acid (GABA) to its receptor, which reduces brain activity and has an anti-anxiety effect. SAGE-217 may also have other effects on neurotransmitters, such as serotonin or dopamine, but this remains unclear.
Proprietà chimiche
Richiesta tecnica su: 3D-HQC05140 SAGE-217
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
